Adenosine A1 Receptor Agonists

Compounds that bind to and stimulate ADENOSINE A1 RECEPTORS.

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2018

Selective partial adenosine a1 receptor agonists in combination with a neutral endopeptidase inhibitor and/or an angiotensin ii receptor antagonist

Barbara E. Albrecht-KüpperS. Vettel
2018
Corpus ID: 109545456

2011

Partial adenosine A1 receptor agonists for cardiovascular therapies

Barbara E. Albrecht-KüpperK. LeineweberP. Nell
Purinergic Signalling Purinergic Signalling
2011
Corpus ID: 255128173

Adenosine, a purine nucleoside, is present in all cells in tightly regulated concentrations. It has many different physiological…

2004

Adenosine Receptor Agonist Pd 81,723 Protects Against Seizure/Status Epilepticus and Neuropathology Following Organophosphate Exposure

J. ComptonS. M. CrawfordRuthie H. RatcliffeKeith H. SteeleR. K. GordonM. Nambiar
2004
Corpus ID: 39271868

Abstract : A novel approach to broad-specificity medical countermeasure against chemical warfare nerve agent (CWNA) poisoning is…

Review

2004

Review

2004

Basic Science: Prejunctional and Presynaptic Trigeminovascular Targets: What Preclinical Evidence Is There?

P. Goadsby
2004
Corpus ID: 71782442

Inhibition of trigeminovascular nociceptive traffic by a prejunctional/presynaptic mechanism is an attractive approach for the…

2001

For processing angiogenesis, selective adenosine a1 receptor agonists, the use of antagonists and allosteric enhancers

タッカー，エイミー・エルプライス，リチャードユーキー，レベッカリンデン，ジョエル
2001
Corpus ID: 90147892

血管新生は、血管新生の増加が望ましい状態の治療に望ましい位置で血管新生を誘導するのに有効な量の選択的アデノシンＡ１アロステリックエンハンサーを投与することによって処理され、当該状態としては、例えば卒中、心疾患、および末梢血管疾患がある。選択的アデノシンＡ１アロステリックエンハンサーは、血管新生の減少が望ましい状態の治療に望ましい位置で血管新生を阻害するのに有効な量で投与され、当該状態としては、例えば腫瘍、糖尿病性網膜症、リウマチ様関接炎や乾癬のような炎症性疾患がある。

2000

Impaired inhibition of epileptiform activity by baclofen, but not by adenosine in the weaver hippocampus